Article
Relative 8q gain predicts disease‐specific survival irrespective of the <i>TMPRSS2‐ERG</i> fusion status in diagnostic biopsies of prostate cancer
16 May 2011
Abstract excerpt
Screening tools have greatly improved prostate cancer (PCa) detection, but the disease course is heterogeneous, and standard clinicopathological parameters do not fully discriminate aggressive from indolent tumors. To evaluate the prognostic value of the TMPRSS2-ERG fusion gene combined with chromosome arm 8q relative gain in diagnostic biopsies of PCa, we studied a consecutive series of 200 diagnostic needle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
